|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/712 |
| (11) | Patento numeris | 2906226 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13845244.6 |
| Europos patento paraiškos padavimo data | 2013-10-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/064479 |
| Data | 2013-10-11 |
| (87) | Numeris | WO 2014/059238 |
| Data | 2014-04-17 |
| (30) | Numeris | Data | Šalis |
| 201261712756 P | 2012-10-11 | US | |
| 201261712780 P | 2012-10-11 | US | |
| 201261723701 P | 2012-11-07 | US | |
| 201361777813 P | 2013-03-12 | US | |
| 201361777851 P | 2013-03-12 | US | |
| 201361777895 P | 2013-03-12 | US |
| (72) |
MACLEOD, Robert, A., US
KIM, Youngsoo, US
ZHOU, Tianyuan, US
FREIER, Susan, M., US
SETH, Punit, P., US
SWAYZE, Eric, US
MONIA, Brett, P., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | MODULATION OF ANDROGEN RECEPTOR EXPRESSION |
| MODULATION OF ANDROGEN RECEPTOR EXPRESSION |